The badge economy, and what it is actually certifying
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 3 of 5 of this archive, newest first.
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A stability programme needs a protocol, defined conditions, a stability-indicating method and time. Time is the ingredient no commercial testing service can sell.
Why the reason for stopping changes what happens afterwards.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.
Follow the resin, not the catalogue.
Efficacy was never the question in this appraisal. Duration of treatment was.
Two signatures — one who performed the work, one who approved its release — are the ordinary regulated convention and are almost unknown here.
The central effects are not a bonus. On the current evidence they are the principal mechanism of weight loss.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The regulated world states the method, the instrument, the convention and the tolerance. This market states a verdict.
Insulin syringes are graduated in units on a convention that fixes 100 units to one millilitre. That convention says nothing about how much peptide is in a unit, and…
The observation that closes a facility is rarely the dramatic one.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A small number of serious gastrointestinal events occur in people taking these drugs. Distinguishing them from the expected effect profile is the most consequential…
Weight reduction in the long programmes flattens at roughly sixty to seventy-two weeks. The timing is consistent, predictable and almost never mentioned in advance.
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
The evidence base is thin and the document says so, which is to its credit.
The limit for a parenteral product is calculable from the dose and the body weight in two lines. Almost nobody in this trade performs the calculation.
Reported from the analysis, not from a warning notice.
The observation that closes a facility is rarely the dramatic one.
The route did not close because of a rule about peptides.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
We asked all four services what they can determine, on what timescale, at what price, and under what accreditation. The answers are printed in full.
These agents produce no dependence and no withdrawal syndrome. What a taper would be for is therefore a real question rather than an obvious one.